REGN31 quarters
Position history for
BNP Paribas Asset Management Holding S.A.'s holdings in Regeneron Pharmaceuticals, Inc.
Yes. BNP Paribas Asset Management Holding holds 331,560 shares of REGN (Regeneron Pharmaceuticals), worth $206.7M, as of its Q2 2026 13F filing. It increased the position by 58,440 shares (+21.4%) from Q1 2026. BNP Paribas Asset Management Holding has held REGN in every 13F on record since Q4 2018, 31 quarterly filings. REGN is 0.2% of BNP Paribas Asset Management Holding's reported 13F portfolio.
Current Value
$206.7M
Current Shares
331,560
Total Value Change
+$206M
Total Shares Change
+329,417
Other major holders of REGN: FMR LLC, VANGUARD GROUP INC